Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma
- 1 January 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Hematology Journal
- Vol. 5 (2), 130-134
- https://doi.org/10.1038/sj.thj.6200374